Brandi Benson’s life underwent a dramatic change when she was diagnosed with terminal cancer (Ewing Sarcoma) during her deployment in Iraq with the U.S. Army in 2009. Despite facing daunting odds of a mere 15% chance of survival and a prognosis of eight to twelve months, Brandi not only defied expectations but also achieved complete recovery, maintaining remission ever since. This transformative experience ignited her passionate dedication to advocating fiercely for cancer patients, survivors, and fellow veterans in similar circumstances.

In 2022, Brandi was honored with a formal invitation to the White House, standing alongside the Hunter Seven Foundation and witnessing the enactment of the PACT ACT law. This expands VA healthcare benefits for veterans exposed to burn pits, Agent Orange, and toxic exposures.

Brandi leverages her platform to share her story of hope and resilience, challenging skeptics and inspiring others to confront adversity with unwavering determination. Her commitment has fostered significant partnerships, including collaborations with Kevin Hines, Bristol Myers Squibb Survivorship Today (led by Sterling K. Brown), and prestigious speaker bureaus like TLC Lions and All-American Entertainment.

Her advocacy spans various fronts. Brandi’s role within the Department of Defense involves providing a crucial consumer perspective in grant and clinical trial reviews focused on Sarcoma cancer research. Drawing on her experiences as a patient and survivor, her insights play a pivotal role in evaluating cancer research addressing urgent issues.

Brandi’s dedication extends to mentoring students at Spelman College through the Braven Nonprofit program, focusing on empowering mentees by enhancing their skills, confidence, experiences, and networks for career advancement.

Brandi Benson is a formidable figure within the cancer community. Her unwavering dedication and outstanding achievements in the fight against cancer rightfully position her at the forefront. Leveraging her voice and personal experience, Brandi continues to drive progress in survivorship and rare diseases with steadfast determination.